News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

John Wallmark, MD

Articles by John Wallmark, MD

Tamoxifen's Impact on the Management of Breast Cancer: The Oncologist's Perspective

ByJohn H. Glick, MD,John Wallmark, MD

February 1st 1997

Breast cancer treatment has evolved greatly within the last 25 years. Tamoxifen was first introduced for the

Latest Updated Articles

Tamoxifen's Impact on the Management of Breast Cancer: The Oncologist's Perspective
February 1st 1997

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)